|
Bharat Electronics announced that the Board of Directors of the Company at its meeting held on 27 February 2026, inter alia, have recommended the interim dividend of Rs 1.95 per equity Share (i.e. 195%) , subject to the approval of the shareholders.
|
|
Caplin Steriles (Caplin), a Subsidiary Company of Caplin Point Laboratories, has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Desmopressin Acetate Injection USP, 4 mcg/mL single-dose vials and 40 mcg/10 mL (4 mcg/mL) multiple-dose vials, a generic therapeutic equivalent version of the Reference Listed Drug (RLD) DDAVP (desmopressin acetate) Injection, 4 mcg/mL of Nordic Pharma Inc., (NDA 018938). Desmopressin Acetate Injection is used to treat conditions like haemophilia A, von Willebrand disease, and central diabetes insipidus, helping to manage bleeding and regulate urine production. According to IQVIATM (IMS Health), Desmopressin Acetate injection USP, 4 mcg/mL single-dose vials and 40 mcg/10 mL (4 mcg/mL) multiple-dose vials had US sales of approximately $26 million for the 12-month period ending December 2025.
|
|
The Board of ICICI Bank at its meeting which concluded today i.e. 28 February 2026, approved purchase of up to 2.0% additional shareholding in its subsidiary, ICICI Prudential Life Insurance Company (ICICI Life). This purchase will primarily be towards maintaining the Bank's majority shareholding in the event of exercise of stock-based compensation of ICICI Life. The above will be subject to receipt of requisite approvals.
|